Cancer Health Treatment Update
Adding a Fourth Drug Improves Outcomes for People With Newly Diagnosed Multiple Myeloma

Four-drug regimens that include Darzalex or Sarclisa outperformed standard three-drug regimens for first-line treatment.

Patients With Metastatic Colorectal Cancer May Continue to Benefit From Immunotherapy
Progression-free survival rates were similar whether or not patients discontinued checkpoint inhibitors after remission.
Cancer Health Winter 2024
Check out our new print edition!
Antibody Drug Ejects Problematic Proteins from Cancer Cells

One type of antibody can glide through certain cells like a ghost walking through a wall.

News From ASH 2023

See all our reports from the American Society of Hemtology blood cancer conference.

News From SABCS 2023
See all our reports from the annual San Antonio Breast Cancer Symposium.
Advertisement
Policy Experts, Scientists, Disability Groups Urge Biden to Address Long COVID Crisis

The authors demand Biden outline the actions his administration is taking to address it in his State of the Union address.

More News About COVID-19
See our coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com.

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2023 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.